Skip to content
Tenfell
Awarded contract
Published 31 Aug 2021

IMPACTT Project - The Supply and Delivery of COVID-19 Samples

Medicines Discovery Catapult · United Kingdom

Key facts

Awarded
30 Jul 2021
Contract starts
31 Jul 2021
Contract ends
31 Jul 2023
Procedure
Open procedure
Buyer type
Other public body

Awarded to 4 suppliers

SupplierValue
TISSUE SOLUTIONS LIMITED—
Immunoserv Ltd—
Logical Biological—
Sera Laboratories International Ltd (trading as BioIVT)—

Description

The Medicines Discovery Catapult Ltd (MDC) has partnered with Oncimmune, who are experts in serological antibody profiling, on the IMPACTT project to create the largest severity based COVID biobank and data registry. The procurement was in two lots: • Lot 1 aimed to deliver a Phase 1 Discovery set of up to 2,000 samples; and • Lot 2 aimed to deliver a Phase 2 Validation set of up to 1,000 samples.

This Framework Agreement is for a 24-month period, with an option to extend for a further 12 months, or until such time as the requisite number of samples (up to 3,000) have been collected (whether this is a shorter or a longer period). The total contract value is up to £500,000.00. The contract runs from August 2021.

Categories (CPV)

Similar open tenders

About Medicines Discovery Catapult

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.